| Name | 8-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-1,4-benzoxazin-3-one | 
|---|---|
| Synonyms | 
                                
                                2H-1,4-BENZOXAZIN-3(4H)-ONE,8-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)
                                
                                
                                 2H-1,4-Benzoxazin-3(4H)-one, 8-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- 8-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE 8-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-1,4-benzoxazin-3(4H)-one  | 
                        
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Boiling Point | 449.8±45.0 °C at 760 mmHg | 
| Molecular Formula | C15H20BNO4 | 
| Molecular Weight | 289.135 | 
| Flash Point | 225.8±28.7 °C | 
| Exact Mass | 289.148529 | 
| PSA | 60.28000 | 
| LogP | 1.71020 | 
| Vapour Pressure | 0.0±1.1 mmHg at 25°C | 
| Index of Refraction | 1.540 | 
| Storage condition | 2-8°C | 
| Hazard Codes | Xn | 
|---|---|
| Risk Phrases | 22-36/37/38 | 
| Safety Phrases | 26-36/39 | 
| HS Code | 2934999090 | 
| 
                                
                                
                                
                                
                                 ~%  
                                    943994-87-4  | 
                        
| Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent: WO2007/77961 A2, 2007 ; Location in patent: Page/Page column 361 ; WO 2007/077961 A2 | 
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 | 
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |